For patients focused on body recomposition, particularly visceral fat reduction alongside lean mass preservation, Tesamorelin offers a clinical evidence base that other peptides in this category cannot match
Histamine vs
A human genetic disease characterized by CPT2 deficiency leads to elevated acylcarnitine levels in serum caused by impaired FAO
Early-phase clinical trials have reported substantial reductions in body weight (Jastreboff et al., New England Journal of Medicine , 2023)
In the primary Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023), retatrutide was studied across several dose levels, including: 1 mg (low dose) 4 mg (mid dose) 8 mg (higher dose) 12 mg (highest dose) These doses were administered as once-weekly subcutaneous injections
Pigment treatments affect a visible part of the skin, so product quality matters